AUG 18, 2026 · PHASE 1 TRIAL
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
ClinicalTrials.gov
Phase 1 trial registration with no results reported; describes planned conduct and safety/dose-finding objectives in an early-stage oncology study.
Reported
Planned enrollment116
PhasePhase 1
Primary outcome measure 1Maximum tolerated dose of metarrestin at 28…